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ABSTRACT
An infection of native joints leads generally to suppurative arthritis, which may be of one joint
(monarticular) or several joints (oligoarticular). Bacteria that produce symptoms in multiple joints
during bacteraemia, such as Neisseria gonorrhoeae, may also induce inﬂammation in the neighbouring
tendon sheaths. Viral infections frequently involve multiple joints and produce inﬂammation without
suppuration. Chronic granulomatous monarticular arthritis may occur because of infection with either
mycobacteria or fungi, which must be differentiated from other causes of chronic monarticular arthritis.
A sterile arthritis may occur early in infection (as with hepatitis B), or later (as with a post-infectious
arthritis). Any patient presenting with an inﬂamed joint should have infection as a diagnostic possibility
and appropriate cultures must be performed.
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PREDISPOSING FACTORS FOR
INFECTIOUS ARTHRITIS
The reported incidence of septic arthritis varies
from 2–5 cases ⁄ 100 000 individuals annually in
the general population, to 28–38 cases ⁄ 100 000
individuals annually among patients with rheu-
matoid arthritis, to 40–68 cases ⁄ 100 000 individu-
als annually among patients with joint prostheses
[1]. Infectious arthritis usually follows haemato-
genous inoculation of pathogenic organisms in
patients predisposed to infectious arthritis
(Table 1). Preceding events include trauma such
as an intra-articular injection, intravenous drug
use, and behaviour associated with sexually
transmitted diseases; predisposing conditions
include underlying rheumatoid arthritis or other
connective tissue disorders, and immunosuppres-
sion, such as that resulting from infection with
human immunodeﬁciency virus (HIV), diabetes
mellitus or immunosuppressive therapy [1,2].
Skin infections have been shown to increase the
predisposition to joint infection of any individual
with an underlying condition such as rheumatoid
arthritis [1,3] Post-infectious arthritis can develop
after infections with sexually transmitted patho-
gens such as Chlamydia, or enteric infections with
Shigella, Salmonella, Campylobacter or Yersinia,
principally in individuals with the speciﬁc histo-
compatibility antigen HLA-B27 (if the triad of
arthritis, conjunctivitis and urethritis is present,
this constitutes Reiter’s syndrome) [2].
CLINICAL FEATURES
Patients with bacterial arthritis present usually
with fever (mild in most cases, with only 30–40%
of individuals having a temperature of >39C),
erythema, swelling, tenderness and a decreased
range of motion of the affected joint(s). The
swelling and joint tenderness can vary from
minimal to severe [3]. The knee is the joint
affected most commonly in both children and
adults with bacterial and mycobacterial arthritis,
followed by the hip, shoulder, wrist and ankle [2].
Diagnosis of bacterial infection of the hip and
shoulder joints is often delayed, since effusions
may be difﬁcult to demonstrate [3].
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Inter-phalangeal joints of the hand are involved
infrequently with bacterial arthritis, but are
involved commonly with viral infections; these
patients present with a rheumatoid arthritis-like
syndrome [4]. Infections of the sacroiliac and
sternoclavicular joints have an association with
parenteral drug abuse. Sacroiliac joints may also
be a site for brucella arthritis, while sternoclavic-
ular septic arthritis can also be a result of infected
central lines, with bacteria entering the joint from
the adjacent subclavian veins [5–7]. Involvement
of multiple joints occurs in up to 10% of patients,
particularly among those with rheumatoid arth-
ritis [3]. Viral arthritis tends to involve multiple
joints, with most patients having symptoms in the
inter-phalangeal joints of the hands and the wrist,
and fewer patients having knee, ankle and elbow
involvement. Inﬂammation of multiple tendon
sheaths (tenosynovitis) occurs commonly with the
disseminated gonococcal syndrome, but may also
be seen with other infectious agents such as
Moraxella, rubella virus and non-tuberculous
mycobacteria, and in sporotrichosis [2].
Acute septic bursitis is caused usually by
Staphylococcus aureus, commonly following local
trauma (77%) [8]. The olecranon and pre-patellar
bursae are the usual sites.
LABORATORY FINDINGS
Patients with bacterial arthritis have an elevated
erythrocyte sedimentation rate, elevation of the
peripheral blood leukocyte count, and a synovial
leukocyte count of > 50 000 ⁄mm3, with >75%
polymorphonuclear leukocytes. However, these
ﬁndings are not speciﬁc for bacterial arthritis
[2,3]. Furthermore, synovial ﬂuid leukocyte
counts of < 28 000 cells ⁄mm3 occur in infected
patients who have malignancy, are receiving
corticosteroids, or are intravenous drug abusers,
although the percentage of segmented neutroph-
ils is > 90% [9]. Protein levels and a low synovial
ﬂuid glucose level are neither sensitive nor
speciﬁc for bacterial arthritis. Leukocyte counts
in patients with bacterial bursitis are >1000 ⁄mm3.
Smears of joint ﬂuid stained for bacteria are
positive in only one-third of cases with bacterial
arthritis, while blood cultures are positive in up to
60% of adults, and joint cultures are positive in
90% of cases [2,3,10]. Other sites to be cultured, if
appropriate, include skin lesions and spinal ﬂuid
in a patient with central nervous system features;
pharyngeal, rectal, cervical or urethral areas
should be cultured for gonococci if disseminated
gonococcal infection (DGI) is suspected. PCR
technology for the detection of bacterial DNA
within the synovial ﬂuid and synovial tissue can be
used to detect Yersinia spp., Chlamydia spp.,Myco-
plasma hominis,Ureaplasma spp., Borrelia burgdorferi
and Neisseria gonorrheae [3]. Cultures of synovial
tissue obtained by needle biopsy or open biopsy
produce higher yields for mycobacterial and fun-
gal infection than do those of synovial ﬂuid.
RADIOLOGICAL AND IMAGING
EVALUATION
The most frequent radiographic abnormalities
observed in association with bacterial arthritis are
related to soft-tissue, including distension of the
joint capsule evidenced by the ‘fat pad’ sign [11]. In
mycobacterial infection, minimal joint space nar-
rowing occurs with marginal erosions and exten-
sive demineralisation (Phemister’s triad) [12].
Sonography, computed tomography and mag-
netic resonance imaging are more sensitive than
radiographs for detecting joint effusions, but are
rarely needed. Magnetic resonance imaging may
be helpful in cases of extra-articular infection [11].
Injection of contrast (arthrography) into joint
spaces has been used to demonstrate hip and
shoulder effusions, but has been replaced
by magnetic resonance imaging. Radionuclide
imaging with three-phase bone scan is useful
for detecting bacterial sacroiliitis, but bone and
gallium scans are otherwise of little use [11].
ACUTE BACTERIAL ARTHRITIS
In infants aged < 1 month, group B streptococci,
Gram-negative bacilli and S. aureus are causative
organisms. S. aureus is the most frequent organ-
ism causing bacterial arthritis in children aged
Table 1. Risk-factors associated with bacterial arthritis
[2,3]
Pre-existing arthritis
Skin infections
Age (> 65 years)
Trauma, including intra-articular injections
Diabetes mellitus
Immunosuppression, e.g., infection with human immunodeﬁciency
virus and immunosuppressive therapy
Intravenous drug abuse
Previous central intravenous catheterisation (sternoclavicular)
Geographical exposure (Lyme’s disease, fungi)
Behaviour associated with sexually transmitted diseases
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>2 years, and is the causative organism in the
vast majority of cases of suppurative arthritis in
adults [2,3]. Staphylococcus epidermidis is isolated
frequently from patients with prosthetic joint
infections [3]. N. gonorrhoeae was once the pre-
dominant cause of bacterial arthritis in young,
sexually active adults, but is seen much less
frequently today.
Although group A b-haemolytic streptococci
are most common, the non-group A streptococci
(groups B, C and G) are also recognised as
signiﬁcant pathogens, particularly group B strep-
tococci with diabetic patients [10]. Streptococcus
pneumoniae occurs as a rare cause of suppurative
arthritis in patients with bacteraemia who do not
necessarily have pneumonia [13].
Infectious arthritis caused by Gram-negative
bacilli is seen in patients with co-morbid condi-
tions, such as intravenous drug abuse, as well as
in hospitalised patients with underlying chronic
arthritis [2,14]. In the past, Pseudomonas aeruginosa
was seen commonly in intravenous drug abusers,
but is nowadays less common [2,3,14]. Kingella
kingae has been recognised increasingly as a cause
of early childhood (aged < 2 years) osteoarticular
infections [15]. Arthritis has also been reported
recently with Arcanobacterium haemolyticum, an
organism associated especially with pharyngitis
and tonsillitis in young individuals [16].
Gonococcal arthritis is caused by organisms
belonging to the protein 1-A serotype, which are
more resistant to serum than strains causing ureth-
ritis [10]. This syndrome, which is now diagnosed
less commonly, manifests as one of two forms: a
polyarticular syndrome with systemic symptoms
such as fever, skin lesions and positive blood
cultures (DGI), or a monarticular suppurative
infection with recovery of the organism from joint
ﬂuid.N. gonorrhoeae canbe recovered fromcultures
of the genital, rectal and pharyngeal areas.
Other microorganisms that can be present in
cases of skin rash and arthritis include Haemophi-
lus inﬂuenzae, Moraxella osloensis, Streptobacillus
moniliformis and Neisseria meningitidis [10]. Pati-
ents with meningococcaemia and DGI syndrome
have been reported to have many more skin
lesions (>100) than those with gonococcal DGI;
some patients also present 5–10 days after the
onset of the infection with sterile joint effusions in
multiple joints which resolve quite rapidly [2].
Speciﬁc epidemiological associations for infec-
tious arthritis are summarised in Table 2. Septic
arthritis following bites can be caused by the
various microorganisms listed in Table 2. Obli-
gate anaerobic bacteria are obtained rarely from
joint ﬂuid, particularly prosthetic joints. An acute
septic arthritis occurs with Mycoplasma hominis
and Ureaplasma urealyticum in post-partum
women and immunocompromised (hypogamma-
globulinaemic) individuals [3].
CHRONIC ARTHRITIS
A polyarthritis of large and small joints has
been reported in the later stages of syphilis [17].
Chronic monarticular arthritis with a granulo-
matous reaction can result from infection with
the mycobacterial or fungal organisms listed
in Table 3. Patients with Mycobacterium tuber-
culosis infections present principally with pain
in a single weight-bearing joint, such as the
knee, with concurrent pulmonary tuberculosis in
23% of cases and immunosuppression in 19%
of cases [18]. Patients with tuberculosis, as well
as those with syphilis, should have an HIV test
performed because of the common association
between these infections. Non-tuberculous
mycobacteria, including Mycobacterium kansasii,
Mycobacterium marinum and members of the
Mycobacterium avium–intracellulare complex, have
a propensity to involve the wrist and hands and
to cause ﬂexor tenosynovitis, carpal tunnel
syndrome and, rarely, olecranon bursitis [2]. In
such a patient with chronic monarticular arth-
ritis, synovial tissue should be cultured for
mycobacteria, including incubation at 30C, as
Mycobacterium marinum grows better at this
temperature. Patients with lepromatous leprosy
and erythema nodosum leprosum may have a
Table 2. Epidemiological associations with infectious
arthritis [2]
Epidemiological association Organism
Female during menstrual cycle or pregnancy;
multiple skin lesions (> 100)
Neisseria gonorrhoeae
Neisseria meningitidis
Human bite Eikenella corrodens,
Fusobacterium nucleatum
Cat or dog bite Pasteurella multocida
Rat bite Streptobacillus moniliformis
Tick exposure Borrelia burgdorferi
(Lyme disease)
Ingestion of unpasteurised dairy products,
e.g., goat milk in Mexico
Brucella spp.
Intravenous drug abuse Pseudomonas aeruginosa
Immunocompromised patients Gram-negative bacilli
Post-partum women and
hypogammaglobulinaemia
Mycoplasma hominis
Trauma in aquatic environment Mycobacterium marinum
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symmetrical polyarthritis of the wrist, metacar-
pals and other small joints of the hands; juxta-
articular erosions can be seen in the carpal
bones [10].
Chronic arthritis of single or multiple joints can
be caused by infection with a number of fungi
(Table 3) [19]. Sporothrix schenckii affects the knee,
wrist or elbow with tenosynovitis. In endemic
areas of the Americas, a chronic arthritis of the
knee occurs in non-white, immunocompromised
men, caused by Coccidioides immitis [10]. Joint
infection occurs rarely in patients with blastomy-
cosis in North America (an infection that spreads
from osteomyelitis) or with Paracoccidioides infec-
tion in South America (involving joints of the long
bones in rural workers).
With Candida spp., infections of the joints
present with an acute onset resulting from hae-
matogenous spread, with polymorphonuclear
leukocytes in synovial ﬂuid; rarely, the fungus
may be introduced during intra-articular cortico-
steroid injection [2]. Pseudallescheria boydii bursitis
or arthritis in rural tropical areas occurs following
penetrating trauma of the knee or elbow. Pene-
trating trauma also precedes a chronic bursitis
with Scedosporium inﬂatum or dematiaceous fungi
such as Exophiala jeanselmei [2,10].
VIRAL ARTHRITIS
Arthritis is a reasonably frequent event resulting
from infection with rubella or mumps virus
(Table 4) [4]. A polyarthritis can develop in adult
women with rubella, lymphocytic choriomenin-
gitis or parvovirus B19 infection [10]. With
rubella, the joint symptoms occur in conjunction
with the rash and involve primarily the small
joints of the hand. Rubella vaccine given to post-
pubertal females can also induce joint symptoms.
In late winter and spring, a symmetrical arthritis
in adults can be seen in women with erythema
infectiosum exposure (‘ﬁfth disease’ in children),
which is an infection caused by parvovirus B19.
Lymphocytic choriomeningitis, caused by an are-
navirus, has also been reported to cause arthritis
in laboratory personnel. In men, arthritis in
multiple large and small joints has been asso-
ciated with mumps [4]. Arthritis develops in up to
20% of patients with hepatitis B infection, in
association with urticaria, between 2 days and
6 weeks before the onset of jaundice. This arthritis
is symmetrical, with a predilection for the hands,
followed by the knees and ankles. Symptoms
usually disappear with the onset of jaundice.
Patients infected with hepatitis C who are in a
mixed cryoglobulinaemic state, present occasion-
ally with arthritis; a positive rheumatoid factor
may present a diagnostic dilemma. A number of
arthropod-borne alphaviruses of the togavirus
family can also cause arthritis (Table 4).
Infrequently, patients infected with human T-
lymphotropic virus type 1have a chronic persistent
oligoarthritis. This is a proliferative synovitis
involving large joints, with atypical lymphocytes
in synovial ﬂuid and pro-viral DNA within tissue
cells [10]. Infection with HIV-1 can produce
arthralgias of multiple joints and, rarely, monar-
ticular arthritis. Thus, HIV infection may mimic
connective tissue disorders, such as Sjogren’s
disorder, and myositis with arthritis. HIV-infected
patients also have a propensity to develop septic
arthritis.
Table 3. Geographical and other associations with differ-
ent forms of chronic monarticular arthritis [10,19]
Organism Association
Bacteria
Brucella spp. Worldwide; unpasteurised
milk products
Tropheryma whipplei Whipple’s disease
Treponema pallidum Syphilis
Mycobacteria and Nocardia
Mycobacterium tuberculosis Worldwide
Mycobacterium kansasii Worldwide
Mycobacterium marinum Aquatic
Mycobacterium avium–intracellulare
complex
Worldwide
Mycobacterium fortuitum Soil
Mycobacterium haemophilum Immunocompromised
Mycobacterium leprae Worldwide
Nocardia asteroides Worldwide
Fungi
Sporothrix schenckii Warm, moist soil
Coccidioides immitis Southwestern USA, Mexico
Blastomyces dermatitidis North America
Paracoccidioides brasiliensis South America
Candida albicans Worldwide
Pseudallescheria boydii Tropical
Table 4. Common associations of viruses causing arthritis
[4]
Common causes of viral arthritis
Adult females with tenosynovitis Rubella
Adult females with erythema
infectiosum exposure
Parvovirus B19
Adult females with aseptic meningitis Lymphocytic
choriomeningitis virus
Adult males Mumps
Pre-icteric phase of serum hepatitis Hepatitis B
Arthropod-borne viruses
East Africa, India Chikungunya
East Africa O’nyong-nyong
Sweden Ockelbo agent
Australia Ross River agent
Barmah Forest virus
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ANTIMICROBIAL THERAPY
Empirical antimicrobial therapy to cover most
pathogens causing bacterial arthritis would
normally be prescribed after obtaining blood
cultures and withdrawing synovial ﬂuid for
culture, Gram’s stain, leukocyte counts and
chemical tests. The choice of drug depends on
the Gram’s stain result and the patient’s age
and history of sexual activity. Previously, cefu-
roxime 100 mg ⁄ kg per day for children, divided
into three daily doses, and 1.5 g every 8 h for
adults could be used to cover both S. aureus and
streptococci [10]. Since more community-
acquired infections in the USA and elsewhere
are now caused by methicillin-resistant S. aure-
us, recommendations for treatment of infections
in such patients, and in those with prosthetic
joints, would include vancomycin 1 g every 12 h
[20]. Ceftriaxone is a reasonable initial choice for
sexually active adults, particularly if they pre-
sent with DGI syndrome. Therapy should be
changed to the optimal and least expensive
agent as soon as culture and susceptibility
results become available.
The usual course of therapy for suppurative
arthritis lasts 2 weeks for H. inﬂuenzae, strep-
tococci or Gram-negative cocci, 3 weeks for
staphylococci, and 4 weeks for pneumococci
or Gram-negative bacilli [10,13]. The DGI
gonococcal arthritis–dermatitis syndrome is
treated with parenteral antibiotics for 2 days
after clinical improvement is noted, followed
by oral therapy to complete treatment for
7–10 days. Gonococcal septic arthritis requires
treatment with parenteral antibiotics for
2 weeks. Mycobacterial infections are treated
with four drugs for 2 months; for tuberculosis,
treatment can then be switched to isoniazid
and rifampicin (if the organisms are susceptible)
for a total of 9–12 months [18]. For non-
mycobacterial organisms, clarithromycin 500 mg
twice-daily may be used in addition. Most
fungal infections are responsive to either ampho-
tericin B or lipid complex, or oral itraconazole.
The Sanford Guide to Antimicrobial Therapy
2005 [21] provides an up-to-date source of
information concerning therapy for speciﬁc
mycobacterial or fungal infections. Approaches
to the special case of prosthetic joint infections
have been summarised recently by Shirtliff and
Mader [22].
OTHER THERAPEUTIC MODALITIES
AND COURSE OF THE ILLNESS
Most individuals with suppurative arthritis
respond adequately to appropriate antimicrobial
agents after an initial joint aspiration for diag-
nosis. Repeated needle aspiration for recurrent
joint effusions and arthroscopic drainage have
both been used with success during the ﬁrst 5–
7 days of treatment, especially if the volume of
synovial ﬂuid, the cell count and the percentage
of polymorphonuclear leukocytes decrease with
each aspiration [3]. Visualisation of joint tissue,
lysis of adhesions, drainage of pockets and
debridement of necrotic material are possible
with arthroscopy [23]. Surgical drainage is
required for joints that are not easily accessible
for needle aspiration, such as the hip and
shoulder, if there is evidence of soft-tissue
extension of infection or if the clinical response
to antimicrobial therapy is inadequate [3]. Treat-
ment with systemic antimicrobial agents should
be continued for up to 1 week after open
drainage, and the wound should be allowed to
close by secondary closure. Surgical drainage of
bacterial bursitis is indicated if there is no
clinical response within 7 days [8].
It is not necessary to immobilise the infected
joint, although weight-bearing should be avoided
until signs of inﬂammation and pain have disap-
peared [3]. Joint contractures are a risk early in the
course of suppurative arthritis, and an active and
passive range of motion exercises may be needed.
The joint should be maintained in the functional
position, and passive motion may be initiated
once the symptoms of pain have subsided. As the
inﬂammation diminishes, active exercises can be
started, and weight-bearing can be permitted
when all signs of inﬂammation have disappeared.
The prognosis following infection in the
elderly, those with infections of the hip and those
with underlying joint disease is poor (Table 5)
[2,3,10]. However, most patients with septic
arthritis immediately following arthroscopy
Table 5. Predictors of poor outcome with bacterial arthri-
tis
Age > 60 years
Pre-existing rheumatoid arthritis
More than four joints affected
Infection in hip and shoulder
Duration of symptoms before treatment of > 1 week
Persistently positive culture after 7 days of appropriate therapy
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experience few sequelae [24]. Infectious causes
of chronic monarticular arthritis are associated
occasionally with substantial residuals, even after
maximal therapy [19].
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